COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.JAMA. 2020 Jun 09; 323(22):2245-2246.JAMA
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
32391855
Citation
Kirkcaldy, Robert D., et al. "COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions." JAMA, vol. 323, no. 22, 2020, pp. 2245-2246.
Kirkcaldy RD, King BA, Brooks JT. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. JAMA. 2020;323(22):2245-2246.
Kirkcaldy, R. D., King, B. A., & Brooks, J. T. (2020). COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. JAMA, 323(22), 2245-2246. https://doi.org/10.1001/jama.2020.7869
Kirkcaldy RD, King BA, Brooks JT. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. JAMA. 2020 Jun 9;323(22):2245-2246. PubMed PMID: 32391855.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.
AU - Kirkcaldy,Robert D,
AU - King,Brian A,
AU - Brooks,John T,
PY - 2020/5/12/pubmed
PY - 2020/10/2/medline
PY - 2020/5/12/entrez
SP - 2245
EP - 2246
JF - JAMA
JO - JAMA
VL - 323
IS - 22
SN - 1538-3598
UR - https://www.unboundmedicine.com/medline/citation/32391855/full_citation
L2 - https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.7869
DB - PRIME
DP - Unbound Medicine
ER -